As of 2026-01-20, the Relative Valuation of Applied Therapeutics Inc (APLT) is (1.29) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.10 USD, the upside of Applied Therapeutics Inc based on Relative Valuation is -1387.7%.
The range of the Relative Valuation is (0.94) - (1.74) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.0x - 13.9x | 9.5x |
| Forward P/E multiples | 7.5x - 14.7x | 11.1x |
| Fair Price | (0.94) - (1.74) | (1.29) |
| Upside | -1039.9% - -1836.9% | -1387.7% |
| Date | P/E |
| 2026-01-12 | -0.79 |
| 2026-01-09 | -0.80 |
| 2026-01-08 | -0.80 |
| 2026-01-07 | -0.85 |
| 2026-01-06 | -0.84 |
| 2026-01-05 | -0.80 |
| 2026-01-02 | -0.82 |
| 2025-12-31 | -0.80 |
| 2025-12-30 | -0.77 |
| 2025-12-29 | -0.84 |
| 2025-12-26 | -0.91 |
| 2025-12-24 | -0.92 |
| 2025-12-23 | -0.92 |
| 2025-12-22 | -1.00 |
| 2025-12-19 | -0.99 |
| 2025-12-18 | -0.98 |
| 2025-12-17 | -0.95 |
| 2025-12-16 | -0.96 |
| 2025-12-15 | -0.93 |
| 2025-12-12 | -0.93 |
| 2025-12-11 | -1.73 |
| 2025-12-10 | -1.75 |
| 2025-12-09 | -1.99 |
| 2025-12-08 | -1.75 |
| 2025-12-05 | -1.72 |
| 2025-12-04 | -1.83 |
| 2025-12-03 | -1.68 |
| 2025-12-02 | -1.69 |
| 2025-12-01 | -1.92 |
| 2025-11-28 | -2.07 |
| 2025-11-26 | -2.10 |
| 2025-11-25 | -1.98 |
| 2025-11-24 | -2.05 |
| 2025-11-21 | -2.06 |
| 2025-11-20 | -2.23 |
| 2025-11-19 | -2.27 |
| 2025-11-18 | -2.37 |
| 2025-11-17 | -2.26 |
| 2025-11-14 | -1.74 |
| 2025-11-13 | -2.15 |
| 2025-11-12 | -7.24 |
| 2025-11-11 | -7.32 |
| 2025-11-10 | -6.68 |
| 2025-11-07 | -6.76 |
| 2025-11-06 | -5.95 |
| 2025-11-05 | -7.08 |
| 2025-11-04 | -8.04 |
| 2025-11-03 | -8.27 |
| 2025-10-31 | -9.15 |
| 2025-10-30 | -8.99 |